Bioprocessing of Human Pluripotent Stem Cells for Cell Therapy Applications
暂无分享,去创建一个
Catarina Brito | Cláudia Correia | Margarida Serra | Paula M. Alves | P. Alves | C. Brito | M. Serra | Cláudia Correia
[1] Jeffrey R. Millman,et al. The effects of low oxygen on self-renewal and differentiation of embryonic stem cells , 2009, Current opinion in organ transplantation.
[2] T. Peura,et al. The generation of six clinical-grade human embryonic stem cell lines. , 2007, Cell stem cell.
[3] Jae Hyun Kim,et al. Maintenance of human pluripotent stem cells using 4SP-hFGF2-secreting STO cells. , 2011, Stem cell research.
[4] Boon Chin Heng,et al. Translating human embryonic stem cells from 2-dimensional to 3-dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. , 2012, Stem cells and development.
[5] J. Lahann,et al. Synthetic polymer coatings for long-term growth of human embryonic stem cells , 2010, Nature Biotechnology.
[6] J. Itskovitz‐Eldor,et al. Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.
[7] L. Lock,et al. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. , 2009, Tissue engineering. Part A.
[8] J. Itskovitz‐Eldor,et al. Controlled, Scalable Embryonic Stem Cell Differentiation Culture , 2004, Stem cells.
[9] Gordana Vunjak-Novakovic,et al. Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. , 2007, Biomaterials.
[10] A. G. Fadeev,et al. Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells , 2010, Nature Biotechnology.
[11] Athanasios Mantalaris,et al. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. , 2008, Biomaterials.
[12] Z. Werb,et al. ECM signalling: orchestrating cell behaviour and misbehaviour. , 1998, Trends in cell biology.
[13] Marc Peschanski,et al. Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. , 2008, Tissue engineering. Part C, Methods.
[14] Sean P Palecek,et al. Development of Scalable Culture Systems for Human Embryonic Stem Cells. , 2010, Biochemical engineering journal.
[15] D. Sahoo,et al. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells , 2011, Nature Biotechnology.
[16] Emmanuel S. Tzanakakis,et al. Stem cells for heart cell therapies. , 2008, Tissue engineering. Part B, Reviews.
[17] Yang Xu,et al. Immunogenicity of induced pluripotent stem cells , 2011, Nature.
[18] J. Aubin,et al. Sustained In Vitro Expansion of Bone Progenitors Is Cell Density Dependent , 2004, Stem cells.
[19] Catarina Brito,et al. Process engineering of human pluripotent stem cells for clinical application. , 2012, Trends in biotechnology.
[20] Robert Zweigerdt,et al. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. , 2010, Stem cell research.
[21] Lisa Mohamet,et al. Abrogation of E-Cadherin-Mediated Cellular Aggregation Allows Proliferation of Pluripotent Mouse Embryonic Stem Cells in Shake Flask Bioreactors , 2010, PloS one.
[22] M. Fraga,et al. Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. , 2012, Stem cells and development.
[23] K. Woodhouse,et al. Control of Human Embryonic Stem Cell Colony and Aggregate Size Heterogeneity Influences Differentiation Trajectories , 2008, Stem cells.
[24] K. Ye,et al. A Synthetic, Xeno-Free Peptide Surface for Expansion and Directed Differentiation of Human Induced Pluripotent Stem Cells , 2012, PloS one.
[25] Gorka Orive,et al. Microcapsules and microcarriers for in situ cell delivery. , 2010, Advanced drug delivery reviews.
[26] B. Yener,et al. The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. , 2009, Tissue engineering. Part B, Reviews.
[27] L. Sharples,et al. Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching , 2005, The Lancet.
[28] S. Palecek,et al. Scalable culture and cryopreservation of human embryonic stem cells on microcarriers , 2009, Biotechnology progress.
[29] Heli Skottman,et al. Good manufacturing practice and clinical-grade human embryonic stem cell lines. , 2008, Human molecular genetics.
[30] Kenneth M. Yamada,et al. Cell interactions with three-dimensional matrices. , 2002, Current opinion in cell biology.
[31] Eugenia Kumacheva,et al. Generation of human embryonic stem cell‐derived mesoderm and cardiac cells using size‐specified aggregates in an oxygen‐controlled bioreactor , 2009, Biotechnology and bioengineering.
[32] Andre Choo,et al. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. , 2010, Tissue engineering. Part C, Methods.
[33] Mayasari Lim,et al. Stem cell bioprocessing: fundamentals and principles , 2009, Journal of The Royal Society Interface.
[34] Thomas Scheper,et al. Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. , 2010, Stem cell research.
[35] S. Reuveny,et al. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. , 2011, Tissue engineering. Part C, Methods.
[36] P. Alves,et al. Microencapsulation Technology: A Powerful Tool for Integrating Expansion and Cryopreservation of Human Embryonic Stem Cells , 2011, PloS one.
[37] J. Malva,et al. Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. , 2011, ACS Nano.
[38] K. Sidhu,et al. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. , 2010, Biomaterials.
[39] J. Hyllner,et al. Human embryonic stem cell technologies and drug discovery , 2009, Journal of cellular physiology.
[40] D. Hess,et al. Extracorporeal tissue engineered liver-assist devices. , 2000, Annual review of biomedical engineering.
[41] F. Watt,et al. High-throughput stem-cell niches , 2011, Nature Methods.
[42] A. Gewirtz,et al. Embryonic and adult stem cell therapy. , 2003, The Journal of allergy and clinical immunology.
[43] David J. Mooney,et al. Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.
[44] J. Itskovitz‐Eldor,et al. Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. , 2008, Stem cells and development.
[45] F. Pampaloni,et al. The third dimension bridges the gap between cell culture and live tissue , 2007, Nature Reviews Molecular Cell Biology.
[46] S. Bonner-Weir,et al. Accurate control of oxygen level in cells during culture on silicone rubber membranes with application to stem cell differentiation , 2009, Biotechnology progress.
[47] Robert Zweigerdt,et al. Scalable expansion of human pluripotent stem cells in suspension culture , 2011, Nature Protocols.
[48] Alan Colman,et al. Cell therapy and the safety of embryonic stem cell-derived grafts. , 2007, Trends in biotechnology.
[49] D. Kaufman,et al. Improved development of human embryonic stem cell‐derived embryoid bodies by stirred vessel cultivation , 2006, Biotechnology and bioengineering.
[50] S. Reuveny,et al. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. , 2011, Stem cell research.
[51] Chris Mason,et al. The impact of manual processing on the expansion and directed differentiation of embryonic stem cells , 2008, Biotechnology and bioengineering.
[52] R. McKay,et al. Cell Contact Regulates Fate Choice by Cortical Stem Cells , 2000, The Journal of Neuroscience.
[53] W. Miller,et al. Bioreactor development for stem cell expansion and controlled differentiation. , 2007, Current opinion in chemical biology.
[54] W. Deng,et al. Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. , 2010, Trends in biotechnology.
[55] Elisa Cimetta,et al. Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. , 2009, Methods.
[56] S. Rehen,et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[57] M. Lako,et al. Concise Review: Putting a Finger on Stem Cell Biology: Zinc Finger Nuclease‐Driven Targeted Genetic Editing in Human Pluripotent Stem Cells , 2011, Stem cells.
[58] K. Chien,et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511 , 2010, Nature Biotechnology.
[59] S. Reuveny,et al. Expansion of human embryonic stem cells on cellulose microcarriers. , 2010, Current protocols in stem cell biology.
[60] Daniel G. Anderson,et al. Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions , 2011, Proceedings of the National Academy of Sciences.
[61] G. Vunjak‐Novakovic,et al. Engineered microenvironments for controlled stem cell differentiation. , 2009, Tissue engineering. Part A.
[62] R. Roberts,et al. Low O2 tensions and the prevention of differentiation of hES cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] Yong-Guang Yang,et al. Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. , 2012, Stem cell research.
[64] A. Choo,et al. Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells. , 2011, Journal of biotechnology.
[65] Alois Jungbauer,et al. Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. , 2012, Tissue engineering. Part A.
[66] L. Lock,et al. Stem/Progenitor cell sources of insulin-producing cells for the treatment of diabetes. , 2007, Tissue engineering.
[67] J. Chaudhuri,et al. Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells , 2010, Biotechnology and bioengineering.
[68] J. Clemente,et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. , 2010, Journal of biotechnology.
[69] J. Hao,et al. Regenerative chemical biology: current challenges and future potential. , 2011, Chemistry & biology.
[70] A. Simpson,et al. Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. , 2006, Cloning and stem cells.
[71] W. Grayson,et al. Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds , 2009, Journal of cellular physiology.
[72] J. Crook,et al. Attachment and growth of human embryonic stem cells on microcarriers. , 2008, Journal of biotechnology.
[73] M. S. Kallos,et al. Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors , 2014, Journal of tissue engineering and regenerative medicine.
[74] Donghui Jing,et al. Cardiac Cell Generation from Encapsulated Embryonic Stem Cells in Static and Scalable Culture Systems , 2010, Cell transplantation.
[75] Gorka Orive,et al. Cell microencapsulation technology: towards clinical application. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[76] O. Lindvall,et al. Stem cell therapy for human neurodegenerative disorders–how to make it work , 2004, Nature Medicine.
[77] Gary D Bader,et al. Dynamic interaction networks in a hierarchically organized tissue , 2010, Molecular systems biology.
[78] Pei-Rong Wang,et al. Generation, Purification and Transplantation of Photoreceptors Derived from Human Induced Pluripotent Stem Cells , 2010, PloS one.
[79] Smadar Cohen,et al. Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation , 2004, Biotechnology and bioengineering.
[80] Kathy O. Lui,et al. Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy. , 2009, Current stem cell research & therapy.
[81] Erkki Ruoslahti,et al. Synthetic surfaces for human embryonic stem cell culture. , 2010, Journal of biotechnology.
[82] M. S. Kallos,et al. Large-scale expansion of pluripotent human embryonic stem cells in stirred-suspension bioreactors. , 2010, Tissue engineering. Part C, Methods.
[83] Yan Li,et al. Differentiation of oligodendrocyte progenitor cells from human embryonic stem cells on vitronectin-derived synthetic peptide acrylate surface. , 2013, Stem cells and development.
[84] D. Kehoe,et al. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. , 2010, Tissue engineering. Part A.
[85] Jean-Pierre Benoit,et al. Adult cell therapy for brain neuronal damages and the role of tissue engineering. , 2010, Biomaterials.
[86] I. Weissman,et al. Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors , 2011, Proceedings of the National Academy of Sciences.
[87] Robert Langer,et al. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.
[88] Y. Hoki,et al. Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.
[89] S. Reuveny,et al. Long-term microcarrier suspension cultures of human embryonic stem cells. , 2009, Stem cell research.
[90] Andre Choo,et al. Perfusion cultures of human embryonic stem cells , 2005, Bioprocess and biosystems engineering.